Tur C - Search Results

1

Progression Independent of Relapse Activity in Multiple Sclerosis: Closer to Solving the Pathologic Puzzle.

Tur C, Rocca MA. Tur C, et al. Neurology. 2024 Jan 9;102(1):e207936. doi: 10.1212/WNL.0000000000207936. Epub 2023 Dec 13. Neurology. 2024. PMID: 38165383

2

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Tintoré M, Rovira A, Río J, Tur C, Pelayo R, Nos C, Téllez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X. Tintoré M, et al. Among authors: tur c. Neurology. 2008 Mar 25;70(13 Pt 2):1079-83. doi: 10.1212/01.wnl.0000280576.73609.c6. Epub 2007 Sep 19. Neurology. 2008. PMID: 17881717

3

Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.

Río J, Rovira A, Tintoré M, Huerga E, Nos C, Tellez N, Tur C, Comabella M, Montalban X. Río J, et al. Among authors: tur c. Mult Scler. 2008 May;14(4):479-84. doi: 10.1177/1352458507085555. Mult Scler. 2008. PMID: 18562504 Clinical Trial.

4

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ. Montalban X, et al. Among authors: tur c. Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7. Mult Scler. 2009. PMID: 19995843

5

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

Tur C, Montalban X, Tintoré M, Nos C, Río J, Aymerich FX, Brieva L, Téllez N, Perkal H, Comabella M, Galán I, Calle D, Sastre-Garriga J, Rovira A. Tur C, et al. Arch Neurol. 2011 Nov;68(11):1421-7. doi: 10.1001/archneurol.2011.241. Arch Neurol. 2011. PMID: 22084124 Clinical Trial.

6

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response.

Río J, Tintoré M, Sastre-Garriga J, Nos C, Castilló J, Tur C, Comabella M, Montalban X. Río J, et al. Among authors: tur c. Eur J Neurol. 2012 Jun;19(6):899-904. doi: 10.1111/j.1468-1331.2011.03648.x. Epub 2012 Jan 31. Eur J Neurol. 2012. PMID: 22289050

7

Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.

Tur C, Wheeler-Kingshott CA, Altmann DR, Miller DH, Thompson AJ, Ciccarelli O. Tur C, et al. Hum Brain Mapp. 2014 Mar;35(3):993-1003. doi: 10.1002/hbm.22229. Epub 2012 Dec 26. Hum Brain Mapp. 2014. PMID: 23281189 Free PMC article.

8

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Tur C, Tintoré M, Vidal-Jordana Á, Bichuetti D, Nieto González P, Arévalo MJ, Arrambide G, Anglada E, Galán I, Castilló J, Nos C, Río J, Martín MI, Comabella M, Sastre-Garriga J, Montalban X. Tur C, et al. PLoS One. 2013 Dec 10;8(12):e82796. doi: 10.1371/journal.pone.0082796. eCollection 2013. PLoS One. 2013. PMID: 24340060 Free PMC article. Clinical Trial.

9

Understanding the role of gender and hormones in multiple sclerosis.

Tintore M, Tur C. Tintore M, et al. Among authors: tur c. Mult Scler. 2014 Apr;20(5):518-9. doi: 10.1177/1352458514528266. Mult Scler. 2014. PMID: 24692502 No abstract available.

10

Secondary progression is not the only explanation.

Palavra F, Tur C, Tintoré M, Rovira À, Montalban X. Palavra F, et al. Among authors: tur c. Acta Med Port. 2014 May-Jun;27(3):393-6. doi: 10.20344/amp.4322. Epub 2014 Jun 30. Acta Med Port. 2014. PMID: 25017353 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters